-
1
-
-
0021806486
-
Chronic lymphocytic leukemia. Recent advances in biology and treatment
-
Gale RP, Foon KA. Chronic lymphocytic leukemia. Recent advances in biology and treatment. Ann Intern Med 1985; 103: 101-120.
-
(1985)
Ann Intern Med
, vol.103
, pp. 101-120
-
-
Gale, R.P.1
Foon, K.A.2
-
2
-
-
0024590614
-
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia
-
Sthoeger ZM, Wakai M. Tse DB, Vinciguerra VP, Allen SL, Budman DR. Lichtman SM, Schulman P, Weiselberg LR, Chiorazzi N. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 1989; 169: 255-268.
-
(1989)
J Exp Med
, vol.169
, pp. 255-268
-
-
Sthoeger, Z.M.1
Wakai, M.2
Tse, D.B.3
Vinciguerra, V.P.4
Allen, S.L.5
Budman, D.R.6
Lichtman, S.M.7
Schulman, P.8
Weiselberg, L.R.9
Chiorazzi, N.10
-
4
-
-
0024556599
-
Spontaneous programmed death (apoplosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro
-
Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JF. Spontaneous programmed death (apoplosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 1989; 71: 343-350.
-
(1989)
Br J Haematol
, vol.71
, pp. 343-350
-
-
Collins, R.J.1
Verschuer, L.A.2
Harmon, B.V.3
Prentice, R.L.4
Pope, J.H.5
Kerr, J.F.6
-
5
-
-
0027955125
-
Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells
-
Fluckiger AC, Durand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994; 179: 91-99.
-
(1994)
J Exp Med
, vol.179
, pp. 91-99
-
-
Fluckiger, A.C.1
Durand, I.2
Banchereau, J.3
-
6
-
-
0026754538
-
Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression
-
Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 1992; 176: 1319-1326.
-
(1992)
J Exp Med
, vol.176
, pp. 1319-1326
-
-
Dancescu, M.1
Rubio-Trujillo, M.2
Biron, G.3
Bron, D.4
Delespesse, G.5
Sarfati, M.6
-
7
-
-
0027455756
-
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia
-
Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993: 177: 213-218.
-
(1993)
J Exp Med
, vol.177
, pp. 213-218
-
-
Buschle, M.1
Campana, D.2
Carding, S.R.3
Richard, C.4
Hoffbrand, A.V.5
Brenner, M.K.6
-
8
-
-
0026584291
-
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
-
Rousset F, Garcia E, Detrance T, Peronne C, Vezzio N, Hsu DH, Kastelein, R, Moore KW, Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890-1893.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 1890-1893
-
-
Rousset, F.1
Garcia, E.2
Detrance, T.3
Peronne, C.4
Vezzio, N.5
Hsu, D.H.6
Kastelein, R.7
Moore, K.W.8
Banchereau, J.9
-
9
-
-
0028356439
-
Cytokine gene expression in B cell chronic lymphocytic leukemia: Evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
-
di Celle PF, Carbone A, Marchis D, Zhou D, Sozzani S, Zupo S, Pini M, Mantovani A, Foa R. Cytokine gene expression in B cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood 1994; 84: 220-228.
-
(1994)
Blood
, vol.84
, pp. 220-228
-
-
Di Celle, P.F.1
Carbone, A.2
Marchis, D.3
Zhou, D.4
Sozzani, S.5
Zupo, S.6
Pini, M.7
Mantovani, A.8
Foa, R.9
-
10
-
-
0027479470
-
Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia
-
Frishman J, Long B, Knospe W, Gregory S, Plate J. Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia. J Exp Med 1993; 177: 955-964.
-
(1993)
J Exp Med
, vol.177
, pp. 955-964
-
-
Frishman, J.1
Long, B.2
Knospe, W.3
Gregory, S.4
Plate, J.5
-
11
-
-
0028960010
-
Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells
-
Long BW, Witte PL, Abraham GN, Gregory SA, Plate JM. Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells. Proc Natl Acad Sci USA 1995; 92: 1416-1420.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 1416-1420
-
-
Long, B.W.1
Witte, P.L.2
Abraham, G.N.3
Gregory, S.A.4
Plate, J.M.5
-
12
-
-
0030749703
-
Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4
-
Vella A, Teague TK, Ihle J, Kappler J, Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 1997; 186: 325-330.
-
(1997)
J Exp Med
, vol.186
, pp. 325-330
-
-
Vella, A.1
Teague, T.K.2
Ihle, J.3
Kappler, J.4
Marrack, P.5
-
13
-
-
0028335948
-
Anchorage dependence, integrins, and apoptosis
-
Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994; 77: 477-478.
-
(1994)
Cell
, vol.77
, pp. 477-478
-
-
Ruoslahti, E.1
Reed, J.C.2
-
14
-
-
0028362831
-
ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells
-
Chong AS, Jiang XL, Scuderi P, Lamas M, Graf LH Jr. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells. Cancer Immunol Immunother 1994; 39: 127-134.
-
(1994)
Cancer Immunol Immunother
, vol.39
, pp. 127-134
-
-
Chong, A.S.1
Jiang, X.L.2
Scuderi, P.3
Lamas, M.4
Graf L.H., Jr.5
-
15
-
-
0025023338
-
The leukocyte cell surface receptor(s) for the iC3b product of complement
-
Rosen H, Law SK. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr Top Microbiol Immunul 1990; 153: 99-122.
-
(1990)
Curr Top Microbiol Immunul
, vol.153
, pp. 99-122
-
-
Rosen, H.1
Law, S.K.2
-
16
-
-
0031422499
-
Signal transduction pathways and mechanisms of apoptosis in CLL B-lymphocytes: Their role in CLL pathogenesis
-
Kipps TJ. Signal transduction pathways and mechanisms of apoptosis in CLL B-lymphocytes: their role in CLL pathogenesis. Hematol Cell Ther 1997; 39 (Suppl 1): S17-S27.
-
(1997)
Hematol Cell Ther
, vol.39
, Issue.SUPPL. 1
-
-
Kipps, T.J.1
-
17
-
-
0027217144
-
Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias
-
Takeuchi H, Katayama I. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias. Leuk Lymphoma 1993; 10: 209-216.
-
(1993)
Leuk Lymphoma
, vol.10
, pp. 209-216
-
-
Takeuchi, H.1
Katayama, I.2
-
19
-
-
0023785753
-
Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3
-
Myones BL, Dalzell JG, Hogg N, Ross GD. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest 1988; 82: 640-651.
-
(1988)
J Clin Invest
, vol.82
, pp. 640-651
-
-
Myones, B.L.1
Dalzell, J.G.2
Hogg, N.3
Ross, G.D.4
-
20
-
-
0027232611
-
Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3
-
Vetvicka V, Reed W, Hoover ML, Ross GD. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J Immunol 1995; 150: 4052-4060.
-
(1995)
J Immunol
, vol.150
, pp. 4052-4060
-
-
Vetvicka, V.1
Reed, W.2
Hoover, M.L.3
Ross, G.D.4
-
22
-
-
0028241856
-
Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain
-
Zhou L, Lee DH, Plescia J, Lau CY, Altieri D. Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J Biol Chem 1994; 269: 17075-17079.
-
(1994)
J Biol Chem
, vol.269
, pp. 17075-17079
-
-
Zhou, L.1
Lee, D.H.2
Plescia, J.3
Lau, C.Y.4
Altieri, D.5
-
24
-
-
0027309118
-
Generation and regeneration of cells of the B-lymphocyte lineage
-
Rolink A, Melchers F. Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 1993; 5: 207-217.
-
(1993)
Curr Opin Immunol
, vol.5
, pp. 207-217
-
-
Rolink, A.1
Melchers, F.2
-
25
-
-
0025125351
-
Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110
-
Freedman AS, Munro JM, Rice GE, Bevilacqua MP, Morimoto C, McIntyre BW, Rhynhart K, Pober JS, Nadler LM. Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science 1990; 249: 1030-1033.
-
(1990)
Science
, vol.249
, pp. 1030-1033
-
-
Freedman, A.S.1
Munro, J.M.2
Rice, G.E.3
Bevilacqua, M.P.4
Morimoto, C.5
McIntyre, B.W.6
Rhynhart, K.7
Pober, J.S.8
Nadler, L.M.9
-
26
-
-
0028195006
-
Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells
-
Koopman G, Keehnen RM, Lindhout E, Newman W, Shimizu Y, van Seventer GA, de Groot C, Pals ST. Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 1994; 152: 3760-5767.
-
(1994)
J Immunol
, vol.152
, pp. 3760-5767
-
-
Koopman, G.1
Keehnen, R.M.2
Lindhout, E.3
Newman, W.4
Shimizu, Y.5
Van Seventer, G.A.6
De Groot, C.7
Pals, S.T.8
-
27
-
-
0028059122
-
Follicular dendritic cells in non-Hodgkin's lymphomas
-
Petrasch S, Brittinger G, Wacker HH, Schmitz J, Kosco-Vilbois M. Follicular dendritic cells in non-Hodgkin's lymphomas. Leuk Lymphoma 1994; 15: 33-43.
-
(1994)
Leuk Lymphoma
, vol.15
, pp. 33-43
-
-
Petrasch, S.1
Brittinger, G.2
Wacker, H.H.3
Schmitz, J.4
Kosco-Vilbois, M.5
-
28
-
-
0026087714
-
Expression of myelomonocytic antigens is associated with unfavourable clinico-prognostic factors in B-cell chronic lymphocytic leukaemia
-
Pinto A, Del Vecchio L, Carbone A, Roncadin M, Volpe R, Serraino D, Monfardini S, Colombatti A, Zagonel V. Expression of myelomonocytic antigens is associated with unfavourable clinico-prognostic factors in B-cell chronic lymphocytic leukaemia. Ann Oncol 1991; 2 (Suppl. 2): 107-113.
-
(1991)
Ann Oncol
, vol.2
, Issue.SUPPL. 2
, pp. 107-113
-
-
Pinto, A.1
Del Vecchio, L.2
Carbone, A.3
Roncadin, M.4
Volpe, R.5
Serraino, D.6
Monfardini, S.7
Colombatti, A.8
Zagonel, V.9
-
29
-
-
0027199119
-
Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: A Cancer and Leukemia Group B study
-
Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunetto VL, Duggan DB, Weiss RB, Royston I, Millard FE et al. Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study. Blood 1993; 82: 1239-1246.
-
(1993)
Blood
, vol.82
, pp. 1239-1246
-
-
Newman, R.A.1
Peterson, B.2
Davey, F.R.3
Brabyn, C.4
Collins, H.5
Brunetto, V.L.6
Duggan, D.B.7
Weiss, R.B.8
Royston, I.9
Millard, F.E.10
-
30
-
-
0028097582
-
Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils
-
Graham IL, Anderson DC, Holers VM, Brown EJ. Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J Cell Biol 1994; 127: 1139-1147.
-
(1994)
J Cell Biol
, vol.127
, pp. 1139-1147
-
-
Graham, I.L.1
Anderson, D.C.2
Holers, V.M.3
Brown, E.J.4
-
31
-
-
0024586548
-
Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia
-
Lowe J, Brown B, Hardie D, Richardson P, Ling N. Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia. Immunol Lett 1989; 20: 103-109.
-
(1989)
Immunol Lett
, vol.20
, pp. 103-109
-
-
Lowe, J.1
Brown, B.2
Hardie, D.3
Richardson, P.4
Ling, N.5
-
32
-
-
0026772281
-
Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B cell non-Hodgkin lymphoma and B cell chronic lymphocytic leukemia
-
Baldini L, Cro L, Calori R, Nobili L, Silvestris I, Maiolo At. Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B cell non-Hodgkin lymphoma and B cell chronic lymphocytic leukemia. Blood 1992; 79: 2688-2693.
-
(1992)
Blood
, vol.79
, pp. 2688-2693
-
-
Baldini, L.1
Cro, L.2
Calori, R.3
Nobili, L.4
Silvestris, I.5
Maiolo, A.6
-
33
-
-
0028265846
-
The leukocyte integrin p150,95 (CD11C/CD18) as a receptor for iCb3. Activation by a heterologous beta subunit and loralization of a ligand recognition site to the I domain
-
Bilsland CA, Diamond MS, Springer TA. The leukocyte integrin p150,95 (CD11C/CD18) as a receptor for iCb3. Activation by a heterologous beta subunit and loralization of a ligand recognition site to the I domain. J Immunol 1994; 152: 4582-4589.
-
(1994)
J Immunol
, vol.152
, pp. 4582-4589
-
-
Bilsland, C.A.1
Diamond, M.S.2
Springer, T.A.3
-
34
-
-
0025195758
-
Leukocyte adhesion molecules deficiency: Its structural basis, pathophysiology and implications for modulating the inflammatory response
-
Arnaout MA. Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 1990; 114: 145-180.
-
(1990)
Immunol Rev
, vol.114
, pp. 145-180
-
-
Arnaout, M.A.1
-
35
-
-
0027530684
-
The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands
-
Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 1993; 120: 1031-1043.
-
(1993)
J Cell Biol
, vol.120
, pp. 1031-1043
-
-
Diamond, M.S.1
Garcia-Aguilar, J.2
Bickford, J.K.3
Corbi, A.L.4
Springer, T.A.5
-
36
-
-
0027483226
-
A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding
-
Michishita M, Videm V, Arnaout MA. A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 1993; 72: 857-867.
-
(1993)
Cell
, vol.72
, pp. 857-867
-
-
Michishita, M.1
Videm, V.2
Arnaout, M.A.3
-
37
-
-
0025195764
-
Structure and function of leukocyte integrins
-
Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev 1990; 114: 181-217.
-
(1990)
Immunol Rev
, vol.114
, pp. 181-217
-
-
Larson, R.S.1
Springer, T.A.2
-
38
-
-
0027621036
-
Dynamic aspects of adhesion receptor function-integrins both twist and shout
-
Humphries MJ, Mould AP, Tuckwell DS. Dynamic aspects of adhesion receptor function-integrins both twist and shout, Bioessays 1993; 15: 391-397.
-
(1993)
Bioessays
, vol.15
, pp. 391-397
-
-
Humphries, M.J.1
Mould, A.P.2
Tuckwell, D.S.3
-
39
-
-
0005482819
-
Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen
-
Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein, SC, Loike ID. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci USA 1998; 85: 7734-7738.
-
(1998)
Proc Natl Acad Sci USA
, vol.85
, pp. 7734-7738
-
-
Wright, S.D.1
Weitz, J.I.2
Huang, A.J.3
Levin, S.M.4
Loike, I.D.5
-
40
-
-
0026569927
-
Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18)
-
Taniguchi-Sidle A, Isenman DE. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). J Biol Chem 1992; 267: 635-643.
-
(1992)
J Biol Chem
, vol.267
, pp. 635-643
-
-
Taniguchi-Sidle, A.1
Isenman, D.E.2
-
41
-
-
0025840355
-
Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18
-
Postigo AA, Corbi AL, Sanchez-Madrid F, de Landazuri MO. Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J Exp Med 1991; 174: 1313-1322.
-
(1991)
J Exp Med
, vol.174
, pp. 1313-1322
-
-
Postigo, A.A.1
Corbi, A.L.2
Sanchez-Madrid, F.3
De Landazuri, M.O.4
-
42
-
-
0026515959
-
In vitro biosynthesis of complement factor I by human endothelial cells
-
Julen N, Dauchel H, Lemercier C, Sim RB, Fontaine M, Ripoche J. In vitro biosynthesis of complement factor I by human endothelial cells. Eur J Ilmmunol 1992; 22: 213-217.
-
(1992)
Eur J Ilmmunol
, vol.22
, pp. 213-217
-
-
Julen, N.1
Dauchel, H.2
Lemercier, C.3
Sim, R.B.4
Fontaine, M.5
Ripoche, J.6
|